Cellular Response to Infectious Triggers
细胞对传染性触发因素的反应
基本信息
- 批准号:6597296
- 负责人:
- 金额:$ 24.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-03-01 至 2005-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long time goal of our studies is to delineate the molecular mechanism that regulates the immune defense against invading pathogens. The study proposed is focused on the role of the family transcription factors of interferon regulatory factors (IRF) in the innate and acquired responses to viral infection. These factors were shown to participate not only in the induction of Type I IFN genes but also in the induction of other cytokines, chemokines and genes directly involved in the antiviral and anti-inflammatory responses. Over the past years we have sequentially isolated IRF-3, IRF-7 and IRF-5 and have shown that these factors serve as direct transporters of virus induced signaling. The function of these factors is not redundant since these factors are expressed in different cell types and stimulate a profile of distinct genes. Among these three factors IRF-7 plays a limiting role in the induction of IFNa that was shown to be important both for the innate and adaptive immune responses. It is our hypothesis that these three IRFs, especially then IRF-7, are regulating both of these immune responses. The key objective of this application is to validate this hypothesis and to determine the molecular mechanism by which IRFs activates the targeted genes in response to pathogens.
The study has three aims.
In Aim#1 we shall examine the molecular mechanism involved in the IRF-7 mediated activation of antiviral genes.
In Aim#2 we shall determine whether Toll 3 and Toll 9 responses to dsRNA and CpG DNA respectively results in the activation of IRF-3, IRF-5 and IRF-7.
In Aim #3 we shall determine whether the stimulation of macrophages and dendritic cells by virus, dsRNA and CpG DNA targets similar or distinct set of antiviral genes.
We believe that the basic understanding of the role of IRF factors in pathogen induced cellular responses will provide a new therapeutic platform for the treatment of the immune and inflammatory disease.
描述(由申请人提供):我们研究的长期目标是描述调节免疫防御入侵病原体的分子机制。本研究的重点是干扰素调节因子(IRF)家族转录因子在病毒感染的先天和获得性反应中的作用。这些因子不仅参与I型IFN基因的诱导,还参与直接参与抗病毒和抗炎反应的其他细胞因子、趋化因子和基因的诱导。在过去的几年里,我们先后分离出IRF-3、IRF-7和IRF-5,并证明这些因子是病毒诱导信号的直接转运体。这些因子的功能不是多余的,因为这些因子在不同的细胞类型中表达,并刺激不同基因的谱。在这三个因子中,IRF-7在诱导IFNa中起限制性作用,而IFNa对先天和适应性免疫反应都很重要。我们的假设是,这三种irf,尤其是IRF-7,调节着这两种免疫反应。本应用程序的关键目标是验证这一假设,并确定IRFs激活目标基因以响应病原体的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paula M Pitha-Rowe其他文献
Paula M Pitha-Rowe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paula M Pitha-Rowe', 18)}}的其他基金
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
8082049 - 财政年份:2010
- 资助金额:
$ 24.53万 - 项目类别:
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
7879743 - 财政年份:2009
- 资助金额:
$ 24.53万 - 项目类别:
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
7436171 - 财政年份:2006
- 资助金额:
$ 24.53万 - 项目类别:
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
7893111 - 财政年份:2006
- 资助金额:
$ 24.53万 - 项目类别:
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
7252075 - 财政年份:2006
- 资助金额:
$ 24.53万 - 项目类别:
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
7149544 - 财政年份:2006
- 资助金额:
$ 24.53万 - 项目类别:
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous
IRF-5 缺陷小鼠的先天抗病毒反应和肿瘤易感性
- 批准号:
7665044 - 财政年份:2006
- 资助金额:
$ 24.53万 - 项目类别:
Role of IRFs in the Innate Response to HIV
IRF 在 HIV 固有反应中的作用
- 批准号:
6695995 - 财政年份:2003
- 资助金额:
$ 24.53万 - 项目类别:
Role of IRFs in the Innate Response to HIV
IRF 在 HIV 固有反应中的作用
- 批准号:
6770058 - 财政年份:2003
- 资助金额:
$ 24.53万 - 项目类别:
相似国自然基金
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
- 批准号:31272541
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
相似海外基金
Impacts of the migratory dendritic cells on tumor-specific T cell fate in the thymus
迁移树突状细胞对胸腺中肿瘤特异性 T 细胞命运的影响
- 批准号:
24K18461 - 财政年份:2024
- 资助金额:
$ 24.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: Understanding the Immunometabolism-Epigenetic Crosstalk in Dendritic Cells
职业:了解树突状细胞中的免疫代谢-表观遗传串扰
- 批准号:
2412256 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Continuing Grant
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
- 批准号:
10753211 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Unified mechanism elucidation of efficacy and side effects of JAK inhibition by targeting dendritic cells
通过靶向树突状细胞抑制 JAK 的功效和副作用的统一机制阐明
- 批准号:
23K06897 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
- 批准号:
10721983 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Homeostatic maintenance and activation of dental pulp quiescent stem/progenitor cells regulated by dendritic cells and macrophages
树突状细胞和巨噬细胞调节的牙髓静止干/祖细胞的稳态维持和激活
- 批准号:
23H03078 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a new cancer immunotherapy using the exosome derived from neoantigen pulsed mature dendritic cells
使用源自新抗原脉冲成熟树突状细胞的外泌体开发新的癌症免疫疗法
- 批准号:
23K08073 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The research of targeting tumor-associated dendritic cells, a new therapy strategy by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
靶向肿瘤相关树突状细胞的研究,树突状细胞介导肿瘤相关抗原的摄取和抗肿瘤反应的新治疗策略
- 批准号:
23K14668 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of plasmacytoid dendritic cells in corneal immunity
浆细胞样树突状细胞在角膜免疫中的作用
- 批准号:
10640026 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别:
Ontogeny and Function of Early-Life Pulmonary Dendritic Cells
早期肺树突状细胞的个体发育和功能
- 批准号:
10667996 - 财政年份:2023
- 资助金额:
$ 24.53万 - 项目类别: